NDC 51407-679-11 - Rizatriptan Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51407-679
- Requested NDC
- 51407-679-11
- Package NDCs from labels
- 51407-679-06, 51407-679-18, 51407-679-11, 51407-679-03
- Manufacturer
- Golden State Medical Supply, Inc. | Aurobindo Pharma Limited
- Effective date
- 2025-08-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ASPARTAME - Golden State Medical Supply, Inc. | Aurobindo Pharma Limited | Golden State Medical Supply, Inc. | Aurobindo Pharma Limited | 2025-08-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51407-679-03 | Rizatriptan Benzoate | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 3 | |
| 51407-679-06 | Rizatriptan Benzoate | 6 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 6 | 3 | |
| 51407-679-11 | Rizatriptan Benzoate | 3 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 3 | 3 | |
| 51407-679-18 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Ascend Laboratories, LLC | 07e66554-bc85-4853-9f40-1249617630a9 | 2022-09-30 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan | RIZATRIPTAN | Macleods Pharmaceuticals Limited | 27bc2cfc-fefb-4b50-a0dc-6268c69b4902 | 2022-07-01 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | 4a5b43f6-a5ea-4d6f-941f-3c19f242c896 | 2022-05-01 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Cipla USA Inc. | f462a507-921c-41c2-93ba-36003b6e8914 | 2022-01-13 | Warnings, Adverse reactions | WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | Bionpharma Inc., | 91e160d6-f23f-e5e0-baec-908b2d25ce3c | 2021-03-02 | Warnings, Adverse reactions | 312837 312839 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Unichem Pharmaceuticals (USA), Inc. | 3cdeccf6-36dd-4a9e-9687-2f7cce47af5f | 2020-04-08 | Warnings, Adverse reactions | 312837 312839 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | f5520526-1cc5-489f-b142-92f92fec77d3 | 2020-02-01 | Warnings, Adverse reactions | 312837 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Teva Pharmaceuticals USA, Inc. | 4ef60c83-ba48-4134-968b-13800ea9b7f2 | 2019-10-01 | Warnings, Adverse reactions | WR978S7QHH |
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | Z0H242BBR1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.